CN Stock MarketDetailed Quotes

000028 China National Accord Medicines Corporation

Watchlist
  • 32.48
  • +2.01+6.60%
Noon Break Nov 18 11:30 CST
18.08BMarket Cap12.26P/E (TTM)

China National Accord Medicines Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

China National Accord Medicines Corporation Q3 2024 Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
18.86B
18.68B
-183.63M
Miss Est.
+3.66%
+2.65%
-0.97%
EPS
0.62
0.58
-0.04
Miss Est.
-4.62%
--
-6.45%
Analyst Rating
Strong Buy

Nov 17, 2024

China National Accord Medicines Corporation Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 19.817B--
--2024/Q4-- / 19.582B--
Oct 29, 20242024/Q318.680B / 18.864B--
Aug 29, 20242024/Q218.695B / 21.205B--
--2024/Q119.090B / 19.860B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 19.817B--
--2024/Q4-- / 19.582B--
Oct 29, 20242024/Q318.680B / 18.864B--
Aug 29, 20242024/Q218.695B / 21.205B--
--2024/Q119.090B / 19.860B--

Unlock Free Earnings Estimates

China National Accord Medicines Corporation Earnings Reports

  • Sinopharm is consistent: report for the third quarter of 2024

    Oct 29 00:00

  • Sinopharm is consistent: quick performance report for the first three quarters of 2024

    Oct 23 00:00

  • Sinopharm is consistent: summary of the 2024 semi-annual report

    Aug 29 00:00

  • Sinopharm is consistent: 2024 semi-annual report

    Aug 29 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 17, 2024

    Strong Buy

    • Strong Buy

      90.00%

    • Buy

      10.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data